4ZJR

RORgamma in complex with inverse agonist 48


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.70 Å
  • R-Value Free: 0.223 
  • R-Value Work: 0.173 
  • R-Value Observed: 0.176 

wwPDB Validation   3D Report Full Report


This is version 1.2 of the entry. See complete history


Literature

Discovery of biaryl carboxylamides as potent ROR gamma inverse agonists.

Chao, J.Enyedy, I.Van Vloten, K.Marcotte, D.Guertin, K.Hutchings, R.Powell, N.Jones, H.Bohnert, T.Peng, C.C.Silvian, L.Hong, V.S.Little, K.Banerjee, D.Peng, L.Taveras, A.Viney, J.L.Fontenot, J.

(2015) Bioorg Med Chem Lett 25: 2991-2997

  • DOI: 10.1016/j.bmcl.2015.05.026
  • Primary Citation of Related Structures:  
    4ZJW, 4ZJR

  • PubMed Abstract: 
  • RORγt is a pivotal regulator of a pro-inflammatory gene expression program implicated in the pathology of several major human immune-mediated diseases. Evidence from mouse models demonstrates that genetic or pharmacological inhibition of RORγ activity can block the production of pathogenic cytokines, including IL-17, and convey therapeutic benefit ...

    RORγt is a pivotal regulator of a pro-inflammatory gene expression program implicated in the pathology of several major human immune-mediated diseases. Evidence from mouse models demonstrates that genetic or pharmacological inhibition of RORγ activity can block the production of pathogenic cytokines, including IL-17, and convey therapeutic benefit. We have identified and developed a biaryl-carboxylamide series of RORγ inverse agonists via a structure based design approach. Co-crystal structures of compounds 16 and 48 supported the design approach and confirmed the key interactions with RORγ protein; the hydrogen bonding with His479 was key to the significant improvement in inverse agonist effect. The results have shown this is a class of potent and selective RORγ inverse agonists, with demonstrated oral bioavailability in rodents.


    Organizational Affiliation

    Immunology Research, Biogen Idec, 12 Cambridge Center, Cambridge, MA 02142, United States.



Macromolecules
Find similar proteins by:  (by identity cutoff)  |  Structure
Entity ID: 1
MoleculeChainsSequence LengthOrganismDetailsImage
Nuclear receptor ROR-gammaA, B, C, D225Homo sapiensMutation(s): 0 
Gene Names: RORCNR1F3RORGRZRG
UniProt & NIH Common Fund Data Resources
Find proteins for P51449 (Homo sapiens)
Explore P51449 
Go to UniProtKB:  P51449
PHAROS:  P51449
Protein Feature View
Expand
  • Reference Sequence
Small Molecules
Ligands 1 Unique
IDChainsName / Formula / InChI Key2D Diagram3D Interactions
4P3
Query on 4P3

Download Ideal Coordinates CCD File 
E [auth A], F [auth B], G [auth C], H [auth D]6-chloro-4'-[(2-chloro-6-fluorobenzoyl)(methyl)amino]-3'-(2,2,2-trifluoroethoxy)biphenyl-3-carboxamide
C23 H16 Cl2 F4 N2 O3
NVMQCZDBIJGVBJ-UHFFFAOYSA-N
 Ligand Interaction
External Ligand Annotations 
IDBinding Affinity (Sequence Identity %)
4P3EC50:  93   nM  BindingDB
4P3IC50:  11   nM  BindingDB
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.70 Å
  • R-Value Free: 0.223 
  • R-Value Work: 0.173 
  • R-Value Observed: 0.176 
  • Space Group: P 31
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 98.409α = 90
b = 98.409β = 90
c = 129.752γ = 120
Software Package:
Software NamePurpose
REFMACrefinement
HKL-2000data collection
SCALEPACKdata scaling
PDB_EXTRACTdata extraction
Cootmodel building
MOLREPphasing
HKL-2000data reduction

Structure Validation

View Full Validation Report



Entry History 

Deposition Data

  • Deposited Date: 2015-04-29 
  • Released Date: 2015-06-17 
  • Deposition Author(s): Marcotte, D.J.

Revision History  (Full details and data files)

  • Version 1.0: 2015-06-17
    Type: Initial release
  • Version 1.1: 2015-06-24
    Changes: Data collection
  • Version 1.2: 2017-11-01
    Changes: Author supporting evidence, Database references, Derived calculations, Source and taxonomy